Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LIPOCOMB 20 MG/10 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LIPOCOMB 20 MG/10 MG CAPSULAS DURAS

Approved

STANDARD

LIPOCOMB 20 MG/10 MG CAPSULAS DURAS

Egis Pharmaceuticals Plc.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 25, 2025
Approval ID: 84d24cb75c69a0ac
Company: Egis Pharmaceuticals Plc.
Type: Standard

Approval Details

Approval Id: 84d24cb75c69a0ac
Drug Cima Aemps Name: LIPOCOMB 20 MG/10 MG CAPSULAS DURAS
Register Number: 3135514C
Holder Company Name: Egis Pharmaceuticals Plc.
Marketing Company Name: Melyfarma S.L.
Authorization Date: 2025-02-25
Dosage Form: CÁPSULA DURA
Dose: 20 mg/10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Egis Pharmaceuticals Plc.

Active Ingredients

ROSUVASTATINA ZINC

21,36 mg

EZETIMIBA

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 25, 2025

Approval ID

84d24cb75c69a0ac

Type

Standard

Back to CIMA-AEMPS Approvals